Mitomycin C induces p53-dependent proliferation arrest in UC-MSCs without full senescence
Background
Human mesenchymal stromal cells (hMSCs) are a promising source for regenerative medicine, but their therapeutic potential is often limited by rapid replicative senescence during ex vivo expansion. This cellular aging process, characterized by cell cycle arrest and altered secretome, can compromise their function and safety. Understanding how hMSCs, particularly umbilical cord-derived mesenchymal stromal cells (UC-MSCs), respond to stress is crucial for optimizing their clinical application. This study investigates the specific features of stress-induced senescence in UC-MSCs to ensure their safe and effective use.
Study Design
Researchers comprehensively analyzed senescence features in human umbilical cord mesenchymal stromal cells (UC-MSCs) 7 days after treatment with mitomycin C (1.5 μg/mL). The study assessed DNA damage via γH2AX/53BP1 foci accumulation, proliferation arrest using Ki-67 staining and colony-forming assays, and cell viability. They also investigated cell cycle arrest pathways, specifically the involvement of p53/p21/p27 and p16. Expression levels of SASP factors (IL-8, PAI-1), COL1A1, and SPARC were measured, alongside assessments for SA-β-gal activity, oxidative stress, mitochondrial dysfunction, and lysosomal accumulation.
Results
UC-MSCs treated with mitomycin C (1.5 μg/mL) exhibited significant DNA double-strand breaks, evidenced by γH2AX/53BP1 foci accumulation. Despite maintaining viability, the cells showed complete proliferation arrest, marked by the absence of Ki-67+ cells and a total loss of colony-forming ability. This cell cycle arrest was mediated by the activation of the p53/p21/p27 pathway, notably without p16 involvement. This unique response meant cells did not acquire a classical senescent phenotype. They did, however, show increased expression of SASP factors like IL-8 and PAI-1, alongside decreased levels of COL1A1 and SPARC. Crucially, markers typically associated with full senescence, such as SA-β-gal activity, oxidative stress, mitochondrial dysfunction, and lysosomal accumulation, were entirely absent.
UC-MSCs exhibited complete proliferation arrest, marked by the absence of Ki-67+ cells and loss of colony-forming ability, yet maintained viability, indicating a p53-dependent arrest without full senescence.
Key Findings
- Mitomycin C (1.5 μg/mL) induced DNA double-strand breaks in UC-MSCs.
- UC-MSCs exhibited complete proliferation arrest (absence of Ki-67+ cells, loss of colony-forming ability) while maintaining viability.
- Cell cycle arrest was mediated by
p53/p21/p27pathway activation, withoutp16involvement. - UC-MSCs did not acquire a classical senescent phenotype;
SA-β-gal, oxidative stress, mitochondrial dysfunction, and lysosomal accumulation were absent. - Increased
IL-8andPAI-1expression, with decreasedCOL1A1andSPARC, indicated altered secretome.
Why It Matters
This study provides critical insights into the stress response of UC-MSCs, which are widely used in regenerative medicine. The finding that UC-MSCs undergo a p53-dependent proliferation arrest without full senescence, even under significant stress, suggests a higher inherent resistance to aging compared to other cell types. This unique resilience could inform improved ex vivo expansion protocols, potentially leading to more robust and safer cell therapies. Understanding this specific stress-induced state can help researchers and clinicians optimize culture conditions, select appropriate cell populations, and develop strategies to prevent detrimental changes that might compromise therapeutic efficacy. It highlights the need to differentiate between various forms of cell cycle arrest and true senescence when evaluating MSC quality.
mitomycin c
uc-mscs
senescence
cell cycle arrest
p53 pathway
regenerative medicine
